Prediction of prostate cancer recurrence after radiation therapy using multiparametric magnetic resonance imaging and spectroscopy: assessment of prognostic factors on pretreatment imaging.

Fiche publication

Date publication

décembre 2022

Journal

Quantitative imaging in medicine and surgery

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BERTAUT Aurélie , Pr CORMIER Luc , Dr MARTIN Etienne , Pr COCHET Alexandre , Pr LOFFROY Romaric

Tous les auteurs :
Asuncion A, Walker PM, Bertaut A, Blanc J, Labarre M, Martin E, Bardet F, Cassin J, Cormier L, Crehange G, Loffroy R, Cochet A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36465820

Résumé

To assess whether data from pre-therapeutic multiparametric magnetic resonance imaging (mpMRI) combined with three-dimensional magnetic resonance spectroscopy (3D MRS) provide prognostic factors of biochemical relapse in patients with localized prostate cancer treated by external radiotherapy or brachytherapy.